secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRONWOOD PHARMACEUTICALS INC (IRWD)
CIK:        0001446847
Form:       8-K
Filed at:   2025-01-29T23:59:59+00:00
Accession:  0001104659-25-007212
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 2.05, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Ironwood cuts workforce ~50%, promotes Gregory Martini to CFO
-------------------------------------------------------------

- Workforce reduction of ~50% approved Jan 17, targeting primarily field-based sales employees; affected employees notified Jan 29.
- Expects to incur $20M-$25M in charges, mostly severance and benefits, substantially in H1 2025; post-reduction headcount ~120.
- Gregory Martini promoted to SVP, CFO effective Jan 27; succeeds Thomas McCourt who remains CEO.
- Martini receives base salary $485k, bonus target 45%, and 111,111 RSUs vesting over 4 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446847/000110465925007212/0001104659-25-007212-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446847/000110465925007212/tm254830d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-007212

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer